IMMUNOLOGICAL PARAMETERS IN BREAST CANCER PATIENTS UNDER BETALEUKIN ADJUVANT TREATMENT
نویسندگان
چکیده
منابع مشابه
Prevalence of Fatty Liver in Breast Cancer Patients Undergoing Treatment
Background and purpose: Fatty liver is one of the most common liver diseases. Some treatments used in breast cancer may be associated with development of fatty liver. The present study aimed at investigating the prevalence of fatty liver in breast cancer patients. Materials and methods: In this cross-sectional study, 117 patients with breast cancer attending Ramsar Imam Sajjad Hospital in 2017...
متن کاملAcute Skin and Pharynx Complications Following Adjuvant Hypofractionated Versus Conventional Radiotherapy in Patients with Breast Cancer
Background: Hypofractionated radiotherapy (HF) method was introduced to overcome the quickly growing tumor cells as well as shortening whole treatment course in solid tumors such as breast cancers. Here, we compared the incidence of dermatitis and pharyngitis among patients undergoing HF versus conventional fractionationated (CF) radiation therapy following surgery for breast cancer. Methods: ...
متن کاملAdjuvant Breast Cancer Treatment: Evolution or Revolution?
F or years, clinicians have appreciated that breast cancer is not one disease, but a family of diseases, each with a distinct natural history and response to treatment. Yet, over the past two decades, adjuvant trials have largely enrolled patients on the basis of tumour size and lymph node status, rather than by biologic features. There were relatively few concessions to the biologic heterogene...
متن کاملAdjuvant Drug Treatment for Resectable Breast Cancer.
Breast cancer is the most common life-threatening malignancy in Western women and the second most common cause of cancer-related death. A paradox in the care of patients with breast cancer is the observation that the majority appear to be curable at the time of initial surgery, yet a large number later experience relapse followed by death from disease. To combat this problem, systemic drug ther...
متن کاملThe impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters
PURPOSE This prospective observational study aimed to evaluate the impact of adjuvant chemotherapy on biological and clinical markers of aging and frailty. METHODS Women ≥ 70 years old with early breast cancer were enrolled after surgery and assigned to a chemotherapy (Docetaxel and Cyclophosphamide) group (CTG, n=57) or control group (CG, n=52) depending on their planned adjuvant treatment. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medical Immunology (Russia)
سال: 2014
ISSN: 2313-741X,1563-0625
DOI: 10.15789/1563-0625-2005-1-63-72